Polypills for the prevention of cardiovascular disease: a framework for wider use

Combinations of cardiovascular medications taken in a single pill — known as polypills — are effective but not widely used, requiring a global shift from physicians, regulators and drug developers.

Saved in:
Bibliographic Details
Published inNature medicine Vol. 28; no. 2; pp. 226 - 229
Main Authors Patel, Anushka, Ojji, Dike, de Silva, H. Asita, MacMahon, Stephen, Rodgers, Anthony
Format Journal Article
LanguageEnglish
Published New York Nature Publishing Group US 01.02.2022
Nature Publishing Group
Subjects
692/499
692/699/75
Aspirin
Biomedical and Life Sciences
Biomedicine
Blood pressure
Cancer Research
Cardiovascular disease
Cardiovascular diseases
Cardiovascular Diseases - prevention & control
Cholesterol
Clinical outcomes
Comment
Disease prevention
Drug Combinations
Drug dosages
Family physicians
Humans
Hypertension
Infectious Diseases
Low density lipoprotein
Metabolic Diseases
Minority & ethnic groups
Molecular Medicine
Neurosciences
Physicians
Primary Prevention
Qualitative research
Online AccessGet full text

Cover

More Information
Summary:Combinations of cardiovascular medications taken in a single pill — known as polypills — are effective but not widely used, requiring a global shift from physicians, regulators and drug developers.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1078-8956
1546-170X
DOI:10.1038/s41591-021-01635-9